Advertisement
Advertisement

GLSI

GLSI logo

Greenwich LifeSciences, Inc.

8.92
USD
+0.08
+0.94%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

8.90

-0.02
-0.20%

Greenwich LifeSciences, Inc. Profile

About

Greenwich LifeSciences Inc. is a clinical stage biopharmaceutical company focuses on the development of cancer immunotherapies for breast cancer and other human epidermal growth factor. The company's product candidate includes GP2, which is in clinical stage. Greenwich LifeSciences Inc.is based in Stafford, Texas.

Info & Links

CEO

Snehal Patel

Headquarters

3992 BLUEBONNET DR, BUILDING 14
STAFFORD, TX 77477, UNITED STATES

Sector

Medical

Auditor

RBSM LLP

Share holders

16

Employees

8

Greenwich LifeSciences, Inc. Statistics

Valuation Measures

Market Capitalization2

118.20M

Enterprise Value

114.11M

Enterprise Value/EBITDA(ttm)

-7.13

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

31.76

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-185.12%

Return on Invested Capital(ttm)

-463.51%

Return on Assets(ttm)

-164.27%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-16.01M

Net Income Available to Common(ttm)

-15.79M

Diluted EPS(ttm)

-0.80

Share Statistics

Beta (5Y Monthly)

1.69

52-Week Change

-30.78%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

13.27M

Dividend Yield

0.00%

Float4

6.35M

% Held by Insiders

51.67%

% Held by Institutions

4.16%

Balance Sheet

Total Cash(mrq)

4.09M

Total Cash Per Share(mrq)

0.31

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.62%

Quick Ratio(mrq)

6.91%

Book Value Per Share(mrq)

0.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.56

Free Cash Flow(ytd)

-7.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement